ZeroStack secured a $6.5 million contract for pharmaceutical distribution in Germany through its wholly owned Phatebo GmbH subsidiary. The order leverages Phatebo’s established logistics network and regulatory expertise to ensure timely, compliant delivery across the German healthcare market.

As part of a broader integration strategy, Phatebo is evaluating AI-enabled tools to boost efficiency, reduce operational risk, and respond dynamically to evolving market demand. These enhancements aim to streamline inventory management, forecasting, and regulatory compliance within the subsidiary’s distribution operations.

Phatebo, ZeroStack’s largest revenue contributor, provides a reliable recurring cash flow base while enabling diversification into the pharmaceutical sector alongside decentralized AI investments. This agreement solidifies the company’s footprint in the European supply chain and underpins plans for further expansion across the continent.